Related Experiment Video
Updated: Jun 16, 2026
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia
Erwin C Puente1, Julie Silverstein, Adam J Bree
1Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University, St. Louis, Missouri, USA.
Diabetes
|January 21, 2010
Summary
Recurrent moderate hypoglycemia can protect the brain from damage caused by severe hypoglycemia. This preconditioning effect reduces neuronal damage and cognitive impairment, offering a beneficial adaptive response.
Area of Science:
- Neuroscience
- Endocrinology
- Metabolic Disorders
Background:
- Intensive glycemic control with insulin therapy increases hypoglycemia risk.
- Clinical reports on cognitive impairment from severe hypoglycemia are variable.
- Recurrent moderate hypoglycemia (RH) may precondition the brain against severe hypoglycemia damage.
Purpose of the Study:
- To investigate if RH protects the brain from damage caused by severe hypoglycemia.
- To assess the impact of RH on neuronal damage and cognitive function after severe hypoglycemia.
Main Methods:
- Rats received either RH (25-40 mg/dl) or saline for 3 days.
- On day 4, rats underwent a severe hypoglycemic clamp (approx. 11 mg/dl).
- Neuronal damage was assessed via staining; cognitive function was tested.
Main Results:
- Severe hypoglycemia caused significant brain damage and cognitive deficits.
- Rats with prior RH experienced 62-74% less brain cell death.
- RH protected against most cognitive disturbances induced by severe hypoglycemia.
Conclusions:
- Antecedent RH preconditioned the brain, limiting neuronal damage and cognitive impairment from severe hypoglycemia.
- RH appears to be a beneficial adaptive response mitigating severe hypoglycemia-induced brain damage.
- This finding has implications for managing diabetes and preventing hypoglycemia-related neurological complications.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.